Abstract
The current presentation will discuss: 1) published findings from one of the first rigorously designed RCTs reporting on the feasibility, tolerability, and preliminary efficacy of an excitatory repetitive transcranial magnetic stimulation (rTMS) to dorsolateral prefrontal cortex (DLPFC) treatment course in youth and young adults with ASD; 2) unpublished results from the same trial showing reduction of depressive symptoms following active compared to sham rTMS; and 3) the protocol for an ongoing rTMS clinical trial to target depression in youth and emerging adults with ASD that includes pre/postneuroimaging to track mechanisms of rTMS-induced brain change.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
